LAMP3 and COVID-19: Our results also coincide with these published findings and show that LGALS9, LAMP3 and PRSS8 are more expressed in hospitalised COVID-19 patients compared to non-hospitalised ones and demonstrated its utility as a predictive biomarker of health risk.